5 Analysts Have This to Say About Roivant Sciences
Portfolio Pulse from Benzinga Insights
5 analysts have rated Roivant Sciences (NASDAQ:ROIV) over the past 3 months, with an average price target of $13.5, up 3.85% from the previous average of $13.00. The current price of Roivant Sciences is $9.41.
June 08, 2023 | 6:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Roivant Sciences (NASDAQ:ROIV) has received 5 analyst ratings in the past 3 months, with an average price target of $13.5, up 3.85% from the previous average. The stock is currently trading at $9.41.
The average price target of $13.5 for Roivant Sciences, which is higher than its current price of $9.41, indicates a potential upside. The increase in the average price target from $13.00 to $13.5 (3.85%) over the past 3 months shows that analysts are becoming more bullish on the stock. This could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100